Quarterly report pursuant to Section 13 or 15(d)

Stock-based compensation - Stock Option Activity (Details)

v3.4.0.3
Stock-based compensation - Stock Option Activity (Details) - Tecogen - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2016
Dec. 31, 2015
Stock Options Outstanding [Roll Forward]    
Beginning (shares) 1,268,200  
Granted (shares) 5,000  
Exercised (shares) 0  
Canceled and forfeited (shares) (150,000)  
Expired (shares) 0  
Ending (shares) 1,123,200 1,268,200
Exercisable (shares) 849,558  
Vested and expected to vest (shares) 1,123,200  
Weighted Average Exercise Price [Roll Forward]    
Beginning (usd per share) $ 3.06  
Granted (usd per share) 3.93  
Exercised (usd per share) 0.00  
Canceled and forfeited (usd per share) 3.39  
Expired (usd per share) 0.00  
Ending (usd per share) 3.02 $ 3.06
Exercisable (usd per share) 2.50  
Vested and expected to vest (usd per share) $ 3.02  
Weighted Average Remaining Life 5 years 5 months 15 days 6 years 5 days
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]    
Outstanding, Aggregate Intrinsic Value $ 1,300,361 $ 985,578
Exercisable, Aggregate Intrinsic Value 1,286,161  
Vested and expected to vest, Aggregate Intrinsic Value $ 1,300,361  
Minimum    
Exercise Price Per Share [Abstract]    
Exercise Price Per Share, Outstanding (per share) $ 1.20 $ 1.20
Maximum    
Exercise Price Per Share [Abstract]    
Exercise Price Per Share, Outstanding (per share) $ 5.39 $ 5.39